loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 29830 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Biophore India Pharmaceuticals Pvt Ltd

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    INTERMEDIATES

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Aspen API. More than just an API.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Biophore India Pharmaceuticals Pvt Ltd (1)

    filter

    01 ACRIVASTINE (1)

    filter

    01 India (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BIOPHORE INDIA PHARMACEUTICALS PVT ...

    Contact Supplier
    • EDQM
    Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    ACRIVASTINE

    PDF Supplier PDF
    URL Supplier Web Content
    29830
    Active
    2015-09-29
    Complete
    2015-12-15
    2015-09-29
    II
    Biophore

    CPhI North America

    Attending

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 29830 of Biophore India Pharmaceuticals Pvt Ltd

    Looking for Drug Master Files (DMF) for 29830 of Biophore India Pharmaceuticals Pvt Ltd 1

    20

    Biophore India Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.

    They are recognized for Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    One of their notable products is ACRIVASTINE, with a corresponding US DMF Number 29830.

    Remarkably, this DMF maintains an Active status since its submission on September 29, 2015, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of December 15, 2015, and payment made on September 29, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY